Amy Rabourn
Treasurer chez OCUPHIRE PHARMA, INC.
Fortune : 12 939 $ au 31/05/2024
Postes actifs de Amy Rabourn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Treasurer | - | - |
| Comptroller/Controller/Auditor | 11/11/2020 | - | |
| Directeur Financier/CFO | 01/12/2019 | 12/02/2024 |
Historique de carrière de Amy Rabourn
Anciens postes connus de Amy Rabourn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/12/2014 | 01/12/2019 |
Formation de Amy Rabourn
| University of Michigan | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| 2 |
Opérationnelle
| Director of Finance/CFO | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
| Ocuphire Pharma, Inc. |
- Bourse
- Insiders
- Amy Rabourn
- Expérience
